Deep inside every chronically failing kidney, a quiet molecular drama unfolds. Scar tissue slowly strangles the delicate ...
A new meta-analysis of six randomized controlled trials shows CagriSema significantly lowers HbA1c, body weight, and blood ...
Five colorectal cancer trials recently began treating patients, testing targeted drugs, bispecific antibodies and ...
Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company ...
Morning Overview on MSN
Prescribed nature activities cut loneliness 17% in a year-long trial of 320 lonely adults
Loneliness scores among 320 lonely adults in Barcelona fell 17% over one year after they were prescribed nature-based social ...
Phase 2b study provides first consistent efficacy signal for a monovalent nucleoprotein-based influenza vaccine across both major influenza A ...
(NASDAQ:VOGX), a clinical-stage developer of novel therapeutics for the treatment of serious metabolic and gastrointestinal ...
Over 80% of assessed basal cell carcinoma lesions regressed across three Gorlin syndrome patients treated with KB113Substantial regression was ...
The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.
The FDA has approved Hovilpri for immunocompromised adults with refractory mucocutaneous HSV lesions, offering a novel oral treatment.
Iambic’s $150 million IPO nets an estimated $135 million and may fund operations through 2028; its lead AI-discovered cancer ...
Pelage Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class regenerative treatments for hair loss, today announced that the first patient has been dosed in the Phase 2/3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results